If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

CE marked release of StoneChecker® Software

11 Dec 2017 07:00

RNS Number : 8823Y
Flying Brands Limited
11 December 2017
 

FLYING BRANDS LIMITED

("Flying Brands" or the "Company")

CE marked release of StoneChecker® Software

Flying Brands PLC (AIM: FBDU) the medical services and software company, is pleased to announce the release of the CE marked version of their StoneChecker® Software, which will pave the way for its adoption across the EU.

Flying Brand's subsidiary company, StoneChecker® Software Ltd, has affixed a CE mark to 'StoneChecker', confirming that the software meets the requirements of the Medical Device Directive (MDD-93/42EEC) and satisfies the quality, safety and performance standards for medical devices in the European Union (EU).

The StoneChecker® Software uses sophisticated statistical techniques to make detailed analyses of kidney stones. The software produces a series of important data in a quick and efficient way to describe key clinical stone variables such as stone volume and measures of stone heterogeneity.

Trevor Brown, Chief Executive of Flying Brands PLC, said:

"Obtaining a CE mark for Stone Checker Software's first product comfortably before the end of the year target has been a significant accomplishment for the agile multidisciplinary Stone Checker team. I share the team's excitement as we prepare to approach the markets now available to us."

 **ENDS**

 

For further information please contact:

 

Flying Brands Limited

Qu Li/Trevor Brown/Vinod Kaushal

Tel: 020 7469 0930

 

Peterhouse Corporate Finance (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRTPBRTMBBMBFR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS